[go: up one dir, main page]

CO4410200A1 - METHODS FOR THE TREATMENT OF OSTEOPOROSIS USING ACTIVE BONE PHOSPHONATES AND PARATHYROID HORMONES - Google Patents

METHODS FOR THE TREATMENT OF OSTEOPOROSIS USING ACTIVE BONE PHOSPHONATES AND PARATHYROID HORMONES

Info

Publication number
CO4410200A1
CO4410200A1 CO96011736A CO96011736A CO4410200A1 CO 4410200 A1 CO4410200 A1 CO 4410200A1 CO 96011736 A CO96011736 A CO 96011736A CO 96011736 A CO96011736 A CO 96011736A CO 4410200 A1 CO4410200 A1 CO 4410200A1
Authority
CO
Colombia
Prior art keywords
phosphonates
osteoporosis
treatment
methods
subject
Prior art date
Application number
CO96011736A
Other languages
Spanish (es)
Inventor
John Althorp Bevan
Ann Dunbar Geddes
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Priority to CO96011736A priority Critical patent/CO4410200A1/en
Publication of CO4410200A1 publication Critical patent/CO4410200A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

6. UN METODO PARA TRATAR A UN SUJETO HUMANO U O- TRO ANIMAL, SEGUN LA REIVINDICACION 5, EN DONDE EL BISFOSFONATO ANTES MENCIONADO ES ACIDO 2-(3-PIRI- DIL)-1-HIDROXIETANO-1,1-BISFOSFONICO. 1. UN METODO PARA TRATAR A UN SUJETO HUMANO U O- TRO ANIMAL QUE TIENE UN TRASTORNO DEL METABOLISMO OSEO, QUE COMPRENDE LOS PASOS DE: (a) ADMINISTRAR AL SUJETO ANTES MENCIONADO UN CANTIDAD SEGURA Y EFICAZ DE UN FOSFONATO OSEO-AC- TIVO, DURANTE UN PERIODO SUPERIOR A 6 MESES, APRO- XIMADAMENTE. (b) ADMINISTRAR AL SUJETO ANTES MENCIONADO UNA CANTIDAD SEGURA Y EFICAZ DE UNA HORMONA PARATIROI- DEA, DURANTE UN PERIODO DE 3 A 12 MESES.6. A METHOD FOR TREATING A HUMAN SUBJECT OR ANOTHER ANIMAL, ACCORDING TO CLAIM 5, WHERE THE BISPHOSPHONATE MENTIONED ABOVE IS ACID 2- (3-PYRIDYL) -1-HYDROXYETHANE-1,1-BISPHOSPHONIC. 1. A METHOD FOR TREATING A HUMAN OR ANOTHER ANIMAL SUBJECT WHO HAS A BONE METABOLISM DISORDER, WHICH INCLUDES THE STEPS OF: (a) ADMINISTERING THE SUBJECT ABOVE A SAFE AND EFFECTIVE AMOUNT OF A BONE-ACUTE PHOSPHONATE , FOR A PERIOD GREATER THAN 6 MONTHS, APPROXIMATELY. (b) ADMINISTER THE SUBJECT ABOVE MENTIONED A SAFE AND EFFECTIVE AMOUNT OF A PARATHYROID HORMONE, DURING A PERIOD OF 3 TO 12 MONTHS.

CO96011736A 1996-03-11 1996-03-11 METHODS FOR THE TREATMENT OF OSTEOPOROSIS USING ACTIVE BONE PHOSPHONATES AND PARATHYROID HORMONES CO4410200A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CO96011736A CO4410200A1 (en) 1996-03-11 1996-03-11 METHODS FOR THE TREATMENT OF OSTEOPOROSIS USING ACTIVE BONE PHOSPHONATES AND PARATHYROID HORMONES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CO96011736A CO4410200A1 (en) 1996-03-11 1996-03-11 METHODS FOR THE TREATMENT OF OSTEOPOROSIS USING ACTIVE BONE PHOSPHONATES AND PARATHYROID HORMONES

Publications (1)

Publication Number Publication Date
CO4410200A1 true CO4410200A1 (en) 1997-01-09

Family

ID=40909676

Family Applications (1)

Application Number Title Priority Date Filing Date
CO96011736A CO4410200A1 (en) 1996-03-11 1996-03-11 METHODS FOR THE TREATMENT OF OSTEOPOROSIS USING ACTIVE BONE PHOSPHONATES AND PARATHYROID HORMONES

Country Status (1)

Country Link
CO (1) CO4410200A1 (en)

Similar Documents

Publication Publication Date Title
RU93054017A (en) METHOD FOR TREATING OSTEOPOROSIS, COMPOSITION FOR TREATING OSTEOPOROSIS, APPLICATION OF ACTIVE PHOSPHONATE AND ESTROGENIC HORMONE FOR TREATING OSTEOPOROSIS
HK1000114A1 (en) Treatment or periodontal disease with alendronate
DK0833643T3 (en) Formulations of anhydrous monosodium salt of alendronate and their use in the treatment of bone disorders
DK0573604T3 (en) Method of treating osteoporosis
NO952131L (en) Method of treating a surgical metal implant
RU94046316A (en) Use of high effective phosphonates for preparing medicinal agents for osteoporosis treatment
ATE236641T1 (en) USE OF BIPHOSPHONATES TO INHIBIT BONE RESORPTION AFTER IMPLANTATION OF ORTHOPEDIC PROSTHESES
ES2190244T3 (en) USE OF THE PARTIROID HORMONE CONSTITUTED BY A SEQUENCE OF AMINO ACIDS 1-34 OF THE HUMAN PARTIROID HORMONE TO REDUCE THE RISK OF VERTEBRAL AND NON-VERTEBRAL BONE FRACTURES.
MX9207349A (en) METHODS FOR THE TREATMENT OF OSTEOPOROSIS USING BISPHOSPHONATES AND PARATHYROID HORMONE.
BR0115696A (en) Use of bisphosphonates for pain management
ES2099245T3 (en) TREATMENT OF OSTEOPOROSIS USING GROWTH HORMONE RELEASE FACTOR (GRF) IN COMBINATION WITH PARATHYROID HORMONE (PTH).
DE69322957D1 (en) L - Deprenyl for the treatment of macular degeneration
ATE293450T1 (en) USE OF BIPHOSPHONY ACIDS TO TREAT ANGIOGENesis
CA2294101A1 (en) A combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor
DE69316013D1 (en) USE OF PHOSPHINATE FOR TREATING OSTEOPOROSIS
IL133172A0 (en) Diphosphonic acid salts for the treatment of osteoporosis
CO4410200A1 (en) METHODS FOR THE TREATMENT OF OSTEOPOROSIS USING ACTIVE BONE PHOSPHONATES AND PARATHYROID HORMONES
PE48597A1 (en) METHOD FOR THE TREATMENT OF OSTEOPOROSIS USING ANTIRESORBENT COMPOUNDS AND PARATHYROID HORMONE
KR970705400A (en) METHODS FOR THE TREATMENT OF OSTEOPOROSIS USING BONE ACTIVE PHOSPHONATES AND PARATHYROID HORMONE USING BONE ACTIVE PHOSPONATE AND PARTHROPHONE HORMONE
IS4392A (en) Pyridyl bisphosphonates for use as medicinal substances
DE68919673D1 (en) METHOD FOR TREATING AND PREVENTING LOSS OF BONE MASS.
AR001226A1 (en) Methods for the treatment of osteoporosis using active phosphonates and parathyroid hormone
CO4700476A1 (en) METHOD FOR THE TREATMENT OF OSTEOPOROSIS USING ANTIRESORPTIVE COMPOUNDS AND PARATHYROID HORMONES
DE69734349D1 (en) TREATMENT OF BONE DRESS WITH ADRENOMEDULLIN
Freeman Southwestern Internal Medicine Conference: Paget’s disease of bone